Literature DB >> 10642229

Response to diphtheria booster vaccination in healthy adults: vaccine trial.

A Vellinga1, P Van Damme, E Joossens, H Goossens.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10642229      PMCID： PMC27267          DOI： 10.1136/bmj.320.7229.217

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union.

Authors:  I R Hardy; S Dittmann; R W Sutter
Journal:  Lancet       Date:  1996-06-22       Impact factor: 79.321

2.  Diphtheria immunity in Flanders.

Authors:  C Matheï; P Van Damme; P Bruynseels; H Goossens; R Vranckx; A Meheus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

3.  Diphtheria: epidemiological update and review of prevention and control strategies.

Authors:  E Prospero; M Raffo; M Bagnoli; R Appignanesi; M M D'Errico
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 4.  Immunization against diphtheria with special emphasis on immunization of adults.

Authors:  A M Galazka; S E Robertson
Journal:  Vaccine       Date:  1996-06       Impact factor: 3.641
  4 in total
  3 in total

1.  Second diphtheria booster in adults raises immunity to 92%.

Authors:  A Vellinga; P Van Damme; E Joosens; M van Der Wielen; H Goossens
Journal:  BMJ       Date:  2001-12-01

2.  Technical and diagnostic performance of five commercial anti-diphtheria toxoid IgG enzyme-linked immunosorbent assay kits.

Authors:  A Faruq; L Dadson; H Cox; F Alcock; A R Parker
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

Review 3.  Adult vaccination against tetanus and diphtheria: the European perspective.

Authors:  B Weinberger
Journal:  Clin Exp Immunol       Date:  2016-07-12       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.